1 Aims and Scope

The CGE Journal publishes original studies, reviews, and opinion pieces offering significance and broad impact to a diverse audience spanning basic, preclinical, clinical, prevention research papers describing original researches and reviews of broad general interest in Cancer - a particular emphasis is placed on Molecular Genetics and Epigenetics.

The journal encourages and publishes articles that report novel findings of wide biological significance in the areas of:

The CGE Journal has a fair and transparent process to rapidly publish important science.

2 Copyright

The authors permanently reserve the copyright for their publications and have granted the rights to any third party in advance for using, reproducing or disseminating the work under the terms of copyright and license of the MedSci Publisher’s constitutions and adopted law and regulations.

3 Manuscripts Submission

3.1 Online submission

Manuscripts must be submitted to Cancer Genetics and Epigenetics (CGE) electronically by MedSci Publisher's online submission system. In cases that online submission system is not available, you can submit your manuscript to the submission email of Cancer Genetics and Epigenetics (CGE): edit@cge.medscipublisher.com. If both of the above ways do not work out, you can directly send your manuscripts to the Publishing Manager by yucuianna@sophiapublisher.ca. The editors will handle your submission within five working days.

Preferred file formats of manuscripts are Microsoft Word and Rich Text Format (RTF). Figures, tables, movies, and raw data can be submitted as supplementally files.

A cover letter must be submitted along with the manuscript during the submission, which should contain a brief explanation of what was previously known, the conceptual advance provided by the findings, and the importance of the findings to a broad readership, as well as how and why their major findings relate to the scope of the journal. Closely related papers submitted elsewhere or in press should be noted in the cover letter and uploaded as additional supplementally files in the online submission system. The cover letter is confidential to the editor and will not be seen by reviewers.

3.2 Corresponding Author

The full name, the contact information, and e-mail address of the corresponding author should be provided. We take the corresponding author as the responsible author, which means that the corresponding author accepts such a responsibility: The corresponding author must warrant that all co-authors have read and approved the authorship of the manuscript, the content of the paper, and its submission to CGE. Official approval of all original authors must be provided before any changes in authorship. All reasonable demands on the necessary materials and methods which can justify the experimental results must be satisfied. Please inform the editorial office if the contact information of the corresponding author changes after submission.

4 Article processing

Scientists all over the world are invited to be as peer reviewers for this journal. All submission will be automatically transferred online to the reviewers by Manuscript Proceeding System in the MedSci Publisher prior to CrossRef’s plagiarism check. (see MedSci Publisher peer review policy for further information)

Cancer Genetics and Epigenetics (CGE) offers a fast publication schedule whilst maintaining rigorous peer review. Normally the publication period is two or four weeks depend on the speed of peer review. Using the recommended manuscript preparation formats will largely speed up the paper procedures and shorten the periods. Research articles will be published electronically in provisional PDF immediately upon acceptance. A fully structured web version and PDF download version will be uploaded within four weeks after acceptance.

Cancer Genetics and Epigenetics (CGE) is affiliated with other medsci journals published by MedSci Publisher, including Journal of Vaccine Research, International Journal of Molecular Medical Science and Journal of Vaccine Research. If referees judge that a manuscript is sound but not of special interest and therefore not appropriate for Cancer Genetics and Epigenetics (CGE), the referee reports can be shared with other journals published by MedSci Publisher. Transferring a manuscript from one journal to another will not incur delays. Conversely, if a manuscript submitted to a sister journal in the MedSci Publisher series is judged to be of exceptional interest by the referees and editors. We may offer publication in Cancer Genetics and Epigenetics (CGE).

5 Article-processing charges

All journals under MedSci Publisher do not require article processing charges (APCs) and offer free publication and free access. However, Open access publications are not without costs. As a publisher, MedSci Publisher needs to pay platform operation fees to publishing platform operators. These fees are used for server rentals, journal publishing systems, publishing databases, access space, software upgrades, and the daily operation and maintenance of the journal publishing system. In order to promote the prosperity and development of open access journals, we encourage research institutions, researchers, and authors publishing in MedSci Publisher journals to make voluntary donations. We appreciate your support for the open access publishing model.